NEW! Investment Companies Centre

Alizyme (AZM)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE Small Cap

Market Cap

£21.84m

Change Today

Price Down-0.62p ()

Share Price

9.88p

Notification of Shares

RNS Number : 4796B
Alizyme PLC
15 August 2008
 



For Immediate Release

15 August 2008


ALIZYME PLC



TR - 1:

NOTIFICATION OF MAJOR INTERESTS IN SHARES


1.     Identity of the issuer or the underlying issuer of existing shares to which voting rights are 
        attached:


       Alizyme plc


2.    Reason for the notification:


     An acquisition or disposal of voting rights



3.    Full name of person(s) subject to the notification obligation:


       Barclays PLC


4.    Full name of shareholder(s) (if different from 3.)


       Barclays Global Investors Ltd

       Barclays Life Assurance Co Ltd

       Barclays Stockbrokers Ltd

       Gerrard Investment Management Ltd


5.    Date of the transaction and date on which the threshold is crossed or reached:


       14 August 2008


6.    Date on which issuer notified:

 

       15 August 2008


7.    Threshold(s) that is/are crossed or reached:


       6 %


8.    Notified details:


A: Voting rights attached to shares


Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights


Direct

Indirect

Direct

Indirect

Ordinary Shares

GB0000374289

13,547,592

13,547,592

12,563,747

-

12,563,747

-

5.68%


B: Financial Instruments


Resulting situation after the triggering transaction

Type of financial instrument 

Expiration date

Exercise/ Conversion

Period/Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights


n/a


n/a


n/a


n/a


n/a







Total (A+B)


Number of voting rights

% of voting rights

12,563,747

5.68%

 

9.    Chain of controlled undertakings through which the voting rights and/or the financial 
       instruments are effectively held, if applicable


       Barclays Global Investors Ltd

       Barclays Life Assurance Co Ltd

       Barclays Stockbrokers Ltd

       Gerrard Investment Management Ltd


Proxy Voting:


10.  Name of the proxy holder:


       n/a


11.  Number of voting rights proxy holder will cease to hold:


       n/a


12.  Date on which proxy holder will cease to hold voting rights:


       n/a


13.  Additional information


       n/a


14.  Contact name:


       David Campbell, Finance Director


15.  Contact telephone number:


      + 44 (0) 1223 896000


For further information, please contact:


David Campbell, Finance Director


ALIZYME plc

Tel No: + 44 (0) 1223 896000


Further information on Alizyme can be found on the Company's website:

www.alizyme.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSFFFMISASESA

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).